I think the next generation of anti-bacterial drugs will be more sophisticated (to a molecular biologist) than the antibiotics we have at the moment. But there may be possible drugs lying around in the filing system of pharma that could be developed if governments could set up some publicly funded research body that would do the work that pharma find economically non-viable. If this was set up pharma might hand over their "possibles" for free.
There are thousands of compounds that they have that proved a dead end for a particular purpose that might be useful for a completely different medical condition.
Makerfield: Reform candidate sexist?


